NATUREX : Financial communications agenda and upcoming events 2012


Avignon, January 10, 2012 - Naturex, world leader in specialty plant-based natural ingredients, discloses its financial communications agenda and the upcoming events for 2012:

Financial Communications

FY 2011 (As of 31.12.2011)
Annual sales 24 January 2012
Annual results 28 March 2012
FY 2012 (As of 31.12.2012)
1st quarter sales 26 April 2012
1st quarter results 29 May 2012
1st half-year sales 25 July 2012
1st half-year results 30 August 2012
3rd quarter sales 5 November 2012
3rd quarter results 29 November 2012
Annual sales 24 January 2013
Annual results 27 March 2013

Each publication will be released after market close (NYSE Euronext Paris).

Upcoming events

Midcap Event
29-30 March 2012
SFAF analyst meeting (annual results)
2 April 2012
Smallcap Event
12-13 April 2012
Consumer Ingredients Event
London - Exane BNP Paribas
22 May 2012
European Midcap Event
New York
30-31 May - 1st June 2012
Annual General Meeting
8 June 2012
SFAF analyst meeting (half-year results)
14 September 2012
Midcap Event
24-25 September 2012
Actionaria trade show
16-17 November 2012
Consumer Ingredients Conference
London - J.P. Morgan
20 November 2012
Midcap Event
10-11 December 2012

If you would like to receive financial information about Naturex by e-mail, go to:

Naturex has been listed since October 1996 on NYSE Euronext Paris, Compartment B (MidCaps)

Number of shares comprising the capital:7,705,580 6,318,272 ordinary shares (ISIN FR0000054694) 1,387,308 preferred shares (ISIN FR0010833251) Naturex is a component of the CAC Small and Gaïa indexes.
Naturex is eligible for "long only" Deferred Settlement Service (SRD).
Naturex has implemented a Sponsored Level I American Depositary Receipt (ADR) program, which trades on over-the-counter market in the United States under symbol NTUXY.

TICKER: NRX - Reuters : NATU.PA - Bloomberg : NRX:FP - DR Symbol: NTUXY

About Naturex

NATUREX is a global leader in specialty plant-based natural ingredients.
The Group is organised around three strategic markets (food & beverage, nutrition & health and personal care) and produces and markets specialty plant-based ingredients for the food, nutraceutical, pharmaceutical and cosmetic industries.

NATUREX's head office is based in Avignon, France. The company employs more than 1,000 people with high-performance manufacturing operations across 14 sites in Europe (France, Italy, Spain, the United Kingdom, Switzerland, Poland), as well as in Morocco, the United States, Brazil and Australia. It also has a global presence through a dedicated network of sales offices in 19 countries (France, Italy, Spain, the United Kingdom, Belgium, Germany, Poland, Russia, U.A.E., Thailand, Singapore, Japan, China, Korea, Australia, the United States, Canada, Brazil and Mexico).

NATUREX's development is supported by positive underlying trends linked to a fast-growing demand for natural products and its capacity to provide manufacturers customised solutions to meet the requirements of their end consumers. The Group's strength lies in its positioning with specific products which constitute niche markets, supported by strong sourcing capacity and sustained research & development.

Jacques Dikansky
President and Chief Executive Officer
Tel.: +33 (0)4 90 23 96 89

Carole Alexandre
Investor Relations
Tel.: +33 (0)4 90 23 78 28
Thierry Lambert
Vice-President and Chief Financial Officer
Tel.: +33 (0)4 90 23 96 89

Anne Catherine Bonjour
Actus Finance Press Relations
Tel.: +33 (0)1 53 67 36 93
Information réglementée
Communiqués au titre de l'obligation d'information permanente :
- Autres communiqués Communiqué intégral et original au format PDF : © Copyright Actusnews Wire
Recevez gratuitement par email les prochains communiqués de la société en vous inscrivant sur
Receive by email the next press releases of the company by registering on, it's free

Valeur associée
  Libellé Bourse Dernier Var. Vol.
Vous devez être membre pour ajouter des commentaires.
Devenez membre, ou connectez-vous.
Aucun commentaire n'est disponible pour l'instant